Dr. Anita Aggarwal
Claim this profileWashington DC VAMC
Studies Embolism
Studies Deep Vein Thrombosis
2 reported clinical trials
3 drugs studied
Area of expertise
1Embolism
Stage III
Stage IV
2Deep Vein Thrombosis
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Anita Aggarwal is currently running
Abelacimab vs Dalteparin
for Blood Clot Prevention in Cancer Patients
This trial compares a new medication, Abelacimab, to another treatment, Dalteparin, in patients with GI or GU cancer who have had blood clots. The goal is to see which treatment better prevents new clots and reduces bleeding risks.
Recruiting2 awards Phase 35 criteria
Abelacimab vs Apixaban
for Cancer-Related Blood Clots
This trial is testing abelacimab, a medication, to prevent blood clots in cancer patients who have had previous clots. It aims to see if it works better and causes fewer bleeding problems compared to a current treatment.
Recruiting2 awards Phase 36 criteria
More about Anita Aggarwal
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Anita Aggarwal has experience with
- Abelacimab
- Apixaban
- Dalteparin
Breakdown of trials Anita Aggarwal has run
Embolism
Deep Vein Thrombosis
Pulmonary Embolism
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anita Aggarwal specialize in?
Anita Aggarwal focuses on Embolism and Deep Vein Thrombosis. In particular, much of their work with Embolism has involved Stage III patients, or patients who are Stage IV.
Is Anita Aggarwal currently recruiting for clinical trials?
Yes, Anita Aggarwal is currently recruiting for 2 clinical trials in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Anita Aggarwal has studied deeply?
Yes, Anita Aggarwal has studied treatments such as Abelacimab, Apixaban, Dalteparin.
What is the best way to schedule an appointment with Anita Aggarwal?
Apply for one of the trials that Anita Aggarwal is conducting.
What is the office address of Anita Aggarwal?
The office of Anita Aggarwal is located at: Washington DC VAMC, Washington, District of Columbia 20422 United States. This is the address for their practice at the Washington DC VAMC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.